J. Qian

The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry

Midie Xu, Dan Huang, Junjie Peng, 2022, Frontiers in Oncology.

Durable benefit from immunotherapy and accompanied lupus erythematosus in pancreatic adenocarcinoma with DNA repair deficiency

Y. Lei, Henghui Zhang, Yu-li Wang, 2020, Journal for ImmunoTherapy of Cancer.

Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma

Lei-na Sun, Changli Wang, Henghui Zhang, 2022, Frontiers in Immunology.

Circulating Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in 11C Choline-identified Oligometastatic Castration-Refractory Prostate Cancer Treated with Stereotactic Ablative Radiotherapy

V. Lowe, W. Harmsen, J. Orme, 2021, medRxiv.

Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer

Dan Huang, S. Cai, Yaqi Li, 2020, Journal for ImmunoTherapy of Cancer.

Prognostic and predictive value of Immunoscore and its correlation with ctDNA in stage II colorectal cancer

J. Galon, P. Ding, Z. Pan, 2023, Oncoimmunology.

The mutation profiles of cell-free DNA in patients with oesophageal squamous cell carcinoma who were responsive and non-responsive to neoadjuvant chemotherapy

Henghui Zhang, Yin Li, T. Zhou, 2020, Journal of thoracic disease.

Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

Changli Wang, Bin Zhang, Henghui Zhang, 2021, Journal for ImmunoTherapy of Cancer.